Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
1.090
-0.020 (-1.80%)
At close: Jan 16, 2026
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $5.71 million as of January 16, 2026. Its market cap has decreased by -92.08% in one year.
Market Cap
5.71M
Enterprise Value
60.52M
Revenue
3.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.09
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from 142.02M to 5.71M, a decrease of -95.98%. That is a compound annual growth rate of -28.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 5.71M | 54.61% |
| Dec 31, 2025 | 3.69M | -94.88% |
| Dec 31, 2024 | 72.05M | -1.32% |
| Dec 29, 2023 | 73.02M | 8.31% |
| Dec 30, 2022 | 67.41M | -58.91% |
| Dec 31, 2021 | 164.08M | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 831.36M |
| Glass House Brands | 739.20M |
| Elite Pharmaceuticals | 511.53M |
| Northwest Biotherapeutics | 446.47M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 335.01M |
| Silence Therapeutics | 262.62M |